Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
1(10%)
Results Posted
0%(0 trials)

Phase Distribution

Ph early_phase_1
1
10%
Ph not_applicable
6
60%
Ph phase_3
2
20%

Phase Distribution

1

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution9 total trials
Early Phase 1First-in-human
1(11.1%)
Phase 3Large-scale testing
2(22.2%)
N/ANon-phased studies
6(66.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

7 of 7 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

10

all time

Status Distribution
Active(2)
Completed(7)
Other(1)

Detailed Status

Completed7
Enrolling by invitation1
Recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Early Phase 11 (11.1%)
Phase 32 (22.2%)
N/A6 (66.7%)

Trials by Status

enrolling_by_invitation110%
recruiting110%
unknown110%
completed770%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
DRUG
Total Trials
10